Select Medical Holdings Corp
NYSE:SEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Select Medical Holdings Corp
NYSE:SEM
|
US |
|
C
|
Comstock Inc
AMEX:LODE
|
US |
|
H
|
Hyfusin Group Holdings Ltd
HKEX:8512
|
HK |
Select Medical Holdings Corp
Select Medical Holdings Corp. operates in a nuanced and complex healthcare environment, transforming the landscape of rehabilitation and critical illness recovery. Founded in 1996, the company embarked on its journey with a vision to bridge gaps in post-acute care, establishing a network that today includes long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient clinics. This vast network caters to individuals requiring extended medical care, rehabilitation, or therapy following serious illnesses or injuries. The company's operational model revolves around specialized healthcare services, offering a continuum of care that supports patient recovery from severe health conditions to regaining independence.
At the heart of Select Medical's business strategy is its ability to monetize diversified segments within healthcare. The company generates revenue through its hospital and outpatient divisions. Long-term acute care hospitals serve patients with critical, acute, and chronic illnesses over extended periods, while inpatient rehabilitation facilities provide intensive therapy and rehabilitation programs. Furthermore, their outpatient rehabilitation clinics offer physical, occupational, and speech therapy to a broader demographic. This multi-faceted approach not only addresses various healthcare needs but also stabilizes revenue streams by reducing dependency on any single segment. By creating a synergy between its service lines, Select Medical positions itself as a comprehensive service provider, maximizing its capability to benefit from the intricate dynamics of the healthcare sector.
Select Medical Holdings Corp. operates in a nuanced and complex healthcare environment, transforming the landscape of rehabilitation and critical illness recovery. Founded in 1996, the company embarked on its journey with a vision to bridge gaps in post-acute care, establishing a network that today includes long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient clinics. This vast network caters to individuals requiring extended medical care, rehabilitation, or therapy following serious illnesses or injuries. The company's operational model revolves around specialized healthcare services, offering a continuum of care that supports patient recovery from severe health conditions to regaining independence.
At the heart of Select Medical's business strategy is its ability to monetize diversified segments within healthcare. The company generates revenue through its hospital and outpatient divisions. Long-term acute care hospitals serve patients with critical, acute, and chronic illnesses over extended periods, while inpatient rehabilitation facilities provide intensive therapy and rehabilitation programs. Furthermore, their outpatient rehabilitation clinics offer physical, occupational, and speech therapy to a broader demographic. This multi-faceted approach not only addresses various healthcare needs but also stabilizes revenue streams by reducing dependency on any single segment. By creating a synergy between its service lines, Select Medical positions itself as a comprehensive service provider, maximizing its capability to benefit from the intricate dynamics of the healthcare sector.
Take-private proposal: The board is reviewing a nonbinding offer from the Executive Chairman to acquire all outstanding shares; no decisions or timing discussed yet.
Revenue growth: All divisions grew revenue in Q4, with total company revenue up over 6% year-over-year and over 5% for the full year.
EBITDA decline: Adjusted EBITDA fell 10% in Q4 to $104.7 million, mainly due to higher health insurance expenses and softness in the outpatient segment.
Outpatient weakness: Outpatient rehab segment saw margin drop to 3.4% amid lower net revenue per visit and $11 million in one-time health insurance and discount impacts.
Robust inpatient rehab: Inpatient rehab division posted strong revenue and census growth, despite some margin pressure from start-up losses tied to new developments.
2026 outlook: Guidance given for 2026: revenue of $5.6–$5.8 billion, adjusted EBITDA of $520–$540 million, and earnings per share of $1.22–$1.32.
Capital allocation: A quarterly cash dividend of $0.0625 per share was declared, and capital spending in 2026 is expected to be $200–$220 million.
